We are live on ! Find out more
CIS

Capital International Sarl Portfolio holdings

AUM $6.11B
1-Year Est. Return 32.29%
This Fund
S&P 500
This Quarter Est. Return
+9.73%
1 Year Est. Return
+32.29%
3 Year Est. Return
+120.6%
5 Year Est. Return
+165.23%
10 Year Est. Return
+684.77%
AUM
$2.23B
AUM Growth
+$248M
Cap. Flow
+$91M
Cap. Flow %
4.08%
Top 10 Hldgs %
26.17%
Holding
234
New
10
Increased
135
Reduced
56
Closed
10

Top Buys

Rank Stock Value
1
ABNB icon
Airbnb
ABNB
+$8.36M
2
TCOM icon
Trip.com Group
TCOM
+$7.36M
3
MSFT icon
Microsoft
MSFT
+$7.29M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$5.14M
5
JNJ icon
Johnson & Johnson
JNJ
+$4.99M

Sector Composition

Rank Sector Weight
1 Technology 23.49%
2 Healthcare 18.67%
3 Consumer Discretionary 13.05%
4 Financials 10.74%
5 Industrials 10.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XYZ
151
Block Inc
XYZ
$47.5B
$2.81M 0.13%
42,196
-40,622
-49% -$2.54M
GM icon
152
General Motors
GM
$76.8B
$2.79M 0.13%
72,426
+5,933
+9% +$205K
ADI icon
153
Analog Devices
ADI
$190B
$2.79M 0.13%
14,296
GILD icon
154
Gilead Sciences
GILD
$165B
$2.78M 0.13%
+36,134
New +$2.88M
DXCM icon
155
DexCom
DXCM
$32B
$2.71M 0.12%
21,107
+2,545
+14% +$308K
B
156
Barrick Mining
B
$73.2B
$2.68M 0.12%
158,280
-4,438
-3% -$80.9K
EOG icon
157
EOG Resources
EOG
$70.7B
$2.63M 0.12%
23,001
-824
-3% -$94.1K
NVO
158
Novo Nordisk
NVO
$209B
$2.63M 0.12%
32,520
-716
-2% -$58.5K
RRX icon
159
Regal Rexnord
RRX
$11.9B
$2.62M 0.12%
17,028
-8,677
-34% -$1.18M
SMAR
160
DELISTED
Smartsheet Inc.
SMAR
$2.59M 0.12%
67,612
+3,246
+5% +$140K
UAL icon
161
United Airlines
UAL
$42.1B
$2.57M 0.12%
46,891
-1,876
-4% -$88.6K
ADBE icon
162
Adobe
ADBE
$105B
$2.55M 0.11%
5,225
-5,321
-50% -$2.14M
WCN
163
Waste Connections
WCN
$42B
$2.55M 0.11%
17,867
-656
-4% -$91.5K
EIX icon
164
Edison International
EIX
$26.4B
$2.53M 0.11%
36,400
LHX icon
165
L3Harris
LHX
$53.4B
$2.52M 0.11%
12,856
+1,792
+16% +$343K
MCD icon
166
McDonald's
MCD
$195B
$2.5M 0.11%
8,378
+1,047
+14% +$304K
AR icon
167
Antero Resources
AR
$10.7B
$2.29M 0.1%
99,439
+8,313
+9% +$185K
EVTC icon
168
Evertec
EVTC
$1.78B
$2.28M 0.1%
61,845
-2
-0% -$69
AZN icon
169
AstraZeneca
AZN
$250B
$2.24M 0.1%
15,631
+2,103
+16% +$309K
PAX icon
170
Patria Investments
PAX
$1.86B
$2.22M 0.1%
155,228
+8,980
+6% +$133K
MRK icon
171
Merck
MRK
$318B
$2.19M 0.1%
19,003
-775
-4% -$88K
ELV icon
172
Elevance Health
ELV
$85.5B
$2.15M 0.1%
4,840
GLOB icon
173
Globant
GLOB
$1.61B
$2.13M 0.1%
11,866
+8,525
+255% +$1.4M
CNP icon
174
CenterPoint Energy
CNP
$26.8B
$2.13M 0.1%
73,099
BNTX icon
175
BioNTech
BNTX
$23.5B
$2.12M 0.1%
19,666
+3,776
+24% +$425K

Similar funds

Capital International Sarl's Q2 2023 Portfolio in Review

As of Q2 2023, Capital International Sarl held 234 positions worth $2.23B, up 13% from $1.98B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Capital International Sarl deployed $91M of net new capital in Q2 2023, opening 10 new positions and adding to 135 existing holdings. Its largest new stake was Johnson & Johnson: 30,888 shares worth $5.11M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $12.5M trimmed.

  • Capital International Sarl's largest Q2 2023 buy was Johnson & Johnson: 30,888 shares worth $5.11M.
  • Capital International Sarl added most to Airbnb in Q2 2023, an estimated $8.36M increase.
  • Capital International Sarl's biggest Q2 2023 reduction was Seagen Inc. Common Stock, cutting an estimated $12.5M.
  • Capital International Sarl fully exited Teva Pharmaceuticals in Q2 2023, selling an estimated $2.79M.
  • Capital International Sarl's ten largest holdings make up 26% of its $2.23B portfolio in Q2 2023.
  • Capital International Sarl opened 10 new positions and closed 10 in Q2 2023.
  • Capital International Sarl's portfolio value rose 13% quarter-over-quarter to $2.23B.

Based on Capital International Sarl's 13F filing for Q2 2023, filed 11 Aug 2023.